Learn from Cynthia M. Fox and 850+ other industry-leading experts.
Browse PlansCynthia M. Fox
PhD, CCC-SLP
Cynthia Fox, PhD, CCC-SLP, received her doctorate degree in speech and hearing sciences from the University of Arizona, Tucson. Her training focused in the areas of neuroscience and motor control. She is an expert on rehabilitation, neuroplasticity, and the role of exercise in the improvement of function consequent to neural injury and disease. She has more than 25 years of experience working in collaboration with expert colleagues conducting efficacy research on Lee Silverman Voice Treatment (LSVT LOUD(R)) in people with Parkinson's disease (PD), as well as studying the underlying mechanisms of speech disorders in PD. Dr. Fox is a world leader in administration of LSVT LOUD speech treatment. She was the first to apply LSVT LOUD to disorders other than PD (e.g., multiple sclerosis) and pioneered the application to pediatric populations, including children with cerebral palsy and Down syndrome. Dr. Fox worked closely on the development of a physical and occupational therapy program, LSVT BIG(R), that was modeled after the LSVT LOUD speech treatment protocol. Dr. Fox has numerous publications in these areas of research and has presented extensively nationally and internationally.
In 2003, Dr. Fox cofounded the company LSVT Global, Inc., to directly address the gap in translation of NIH-funded clinical treatment research (i.e., LSVT LOUD and LSVT BIG) to public health practice. LSVT Global achieves this goal through an extensive clinician training curriculum with in-person, virtual live, and online courses; LSVT Companion speech software; and exercise tools for patient populations. Dr. Fox is a faculty member for both LSVT LOUD and LSVT BIG training and certification courses. Currently there are more than 50,000 speech, physical, and occupational therapists in 78 countries trained to deliver the LSVT protocols. Dr. Fox is a chief executive officer of LSVT Global, Inc.
Courses with Cynthia M. Fox
Browse Course CatalogChildhood Motor Speech Disorders: Neuroplasticity and LSVT LOUD
Presented by Cynthia M. Fox, PhD, CCC-SLP
Childhood Motor Speech Disorders: Neuroplasticity and LSVT LOUD
Subscribe now, and access clinical education
and patient education—anytime, anywhere—with video instruction from
recognized industry experts.
Video Runtime: 62 Minutes; Learning Assessment Time: 29 Minutes
Understanding key principles that drive activity-dependent neuroplasticity may help guide clinicians in choosing the most appropriate treatment targets and mode of treatment delivery for children with pediatric motor speech disorders. This course will review key principles that are essential to driving activity-dependent neuroplasticity in pediatric populations. We will demonstrate how these principles can be integrated into a treatment protocol (Lee Silverman Voice Treatment [LSVT LOUD]) for pediatric clients, specifically children with dysarthria consequent to cerebral palsy (CP) or Down syndrome (DS). Research outcomes across acoustic, perceptual, and physiological levels will be discussed. Further, fast-phase and slow-phase neural changes in these children, as evidenced by structural and functional neuroimaging studies, will be explored. Finally, a review of tips for real-world implementation of intensive treatment programs for children dysarthria consequent to CP or DS will be discussed.
Understanding key principles that drive activity-dependent neuroplasticity may help guide clinicians in choosing the most appropriate treatment targets and mode of treatment delivery for children with pediatric motor speech disorders. This course will review key principles that are essential to driving activity-dependent neuroplasticity in pediatric populations. We will demonstrate how these principles can be integrated into a treatment protocol (Lee Silverman Voice Treatment [LSVT LOUD]) for pediatric clients, specifically children with dysarthria consequent to cerebral palsy (CP) or Down syndrome (DS). Research outcomes across acoustic, perceptual, and physiological levels will be discussed. Further, fast-phase and slow-phase neural changes in these children, as evidenced by structural and functional neuroimaging studies, will be explored. Finally, a review of tips for real-world implementation of intensive treatment programs for children dysarthria consequent to CP or DS will be discussed.
Speech Treatment Post Deep Brain Stimulation in Parkinson’s Disease
Presented by Cynthia M. Fox, PhD, CCC-SLP
Speech Treatment Post Deep Brain Stimulation in Parkinson’s Disease
Subscribe now, and access clinical education
and patient education—anytime, anywhere—with video instruction from
recognized industry experts.
Video Runtime: 78 Minutes; Learning Assessment Time: 29 Minutes
Deep brain stimulation (DBS) surgery is an effective treatment for select motor symptoms in people with Parkinson's disease (PD). Unfortunately, speech and voice symptoms are not consistently improved post DBS surgery, and in some cases are worsened. Understanding the impact of DBS on speech and effective speech treatment approaches has the potential to improve communication outcomes for people post DBS. This course will briefly describe DBS surgery for PD, inform participants about voice and speech changes often encountered in individuals post DBS, and describe research on the impact of electrode placement of DBS targeting the subthalamic nucleus (DBS-STN) on voice and speech in people with PD. Research on the longitudinal effects of DBS-STN on speech and voice and how speech treatment (LSVT LOUD) may improve communication post DBS-STN will be explored. Finally, additional treatment options that may maximize speech and communication for patients post DBS-STN will be reviewed.
Deep brain stimulation (DBS) surgery is an effective treatment for select motor symptoms in people with Parkinson's disease (PD). Unfortunately, speech and voice symptoms are not consistently improved post DBS surgery, and in some cases are worsened. Understanding the impact of DBS on speech and effective speech treatment approaches has the potential to improve communication outcomes for people post DBS. This course will briefly describe DBS surgery for PD, inform participants about voice and speech changes often encountered in individuals post DBS, and describe research on the impact of electrode placement of DBS targeting the subthalamic nucleus (DBS-STN) on voice and speech in people with PD. Research on the longitudinal effects of DBS-STN on speech and voice and how speech treatment (LSVT LOUD) may improve communication post DBS-STN will be explored. Finally, additional treatment options that may maximize speech and communication for patients post DBS-STN will be reviewed.
Interprofessional Practice for Parkinson's: LSVT BIG and LSVT LOUD
Presented by Cynthia M. Fox, PhD, CCC-SLP, Laura Gusé, MPT, and Erica Vitek, MOT, OTR, BCB-PMD, PRPC
Interprofessional Practice for Parkinson's: LSVT BIG and LSVT LOUD
Subscribe now, and access clinical education
and patient education—anytime, anywhere—with video instruction from
recognized industry experts.
Video Runtime: 84 Minutes; Learning Assessment Time: 37 Minutes
Parkinson's disease and other neurological disorders are complex and often require intervention by all three rehabilitation disciplines: physical, occupational, and speech therapy. Too often, therapists work in silos despite overlapping patient goals. This forfeits holistic, patient-centered care and can cause confusion for the patient. This course will present an example of a unified approach across physical, occupational, and speech therapies (LSVT BIG and LSVT LOUD) to comprehensively treat cross-system deficits in people with PD. Integration of patient-specific goals and utilization of other healthcare- and community-based professionals will be explored.
Parkinson's disease and other neurological disorders are complex and often require intervention by all three rehabilitation disciplines: physical, occupational, and speech therapy. Too often, therapists work in silos despite overlapping patient goals. This forfeits holistic, patient-centered care and can cause confusion for the patient. This course will present an example of a unified approach across physical, occupational, and speech therapies (LSVT BIG and LSVT LOUD) to comprehensively treat cross-system deficits in people with PD. Integration of patient-specific goals and utilization of other healthcare- and community-based professionals will be explored.
Sensory Recalibration for Improving Speech in Parkinson’s Disease
Presented by Cynthia M. Fox, PhD, CCC-SLP
Sensory Recalibration for Improving Speech in Parkinson’s Disease
Subscribe now, and access clinical education
and patient education—anytime, anywhere—with video instruction from
recognized industry experts.
Video Runtime: 67 Minutes; Learning Assessment Time: 32 Minutes
The underlying mechanism of speech disorders in Parkinson's disease (PD) has traditionally been linked to the motor signs of rigidity and hypokinesia/bradykinesia. However, abnormalities of the sensory system, including difficulties self-monitoring normal vocal loudness, have come to light as important contributors to the voice and speech difficulties of people with PD. Understanding these central sensory processing deficits may facilitate improved understanding of successful speech treatment and improved functional communication for people with PD. This course will discuss motor and nonmotor disorders that impact voice, speech, and communication in people with PD, with a focus on sensory deficits. Barriers that make generalization of speech treatment improvements for people with PD outside of the treatment room challenging will be explored. The course will explain the four key components of the speech treatment Lee Silverman Voice Treatment (LSVT LOUD) that specifically address the sensory disorder in people with PD. Finally, the course will discuss behavioral and neural correlates (from PET and fMRI imaging studies) of treatment-related changes in sensory recalibration post LSVT LOUD.
The underlying mechanism of speech disorders in Parkinson's disease (PD) has traditionally been linked to the motor signs of rigidity and hypokinesia/bradykinesia. However, abnormalities of the sensory system, including difficulties self-monitoring normal vocal loudness, have come to light as important contributors to the voice and speech difficulties of people with PD. Understanding these central sensory processing deficits may facilitate improved understanding of successful speech treatment and improved functional communication for people with PD. This course will discuss motor and nonmotor disorders that impact voice, speech, and communication in people with PD, with a focus on sensory deficits. Barriers that make generalization of speech treatment improvements for people with PD outside of the treatment room challenging will be explored. The course will explain the four key components of the speech treatment Lee Silverman Voice Treatment (LSVT LOUD) that specifically address the sensory disorder in people with PD. Finally, the course will discuss behavioral and neural correlates (from PET and fMRI imaging studies) of treatment-related changes in sensory recalibration post LSVT LOUD.
Start any course for free!
Get access to the first chapter of all 2600+ courses when you create a free account.
Sign Up for Free